Pharmacogenetic Testing
7
0
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Pharmacogenomic and Circulating Biomarkers for CDK4/6 Inhibitors
Trial of Preemptive Pharmacogenetics in Underserved Patients
Pharmacogenetic Testing at Community Pharmacy
Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population
Pilot of Preemptive Pharmacogenetics in Medically Underserved Patients
Pharmacist-led Pharmacogenomic Clinical Service Within the Program of All-inclusive Care for the Elderly
Pharmacogenetic Testing in Primary Care